A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics
|
|||||
A wearable robotic exoskeleton designed into textiles to provide personalized assistance is shown in lab and field tests to reduce the amount effort needed to walk long distances. . . . → Read More: Exosuit Designed for Personalized Walking Help 
Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver. . . . → Read More: Gilead Gains Genome-Editing Hepatitis B Therapy 
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs 
A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer  2 comments - (Comments are closed)  Joint ventures/collaborations  biomedical, biotechnology, cancer, clinical trials, genomics, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing. . . . → Read More: Genomics-Blockchain Company Launches, Raises $4.3 Million One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, blockchain, computer science, engineering, entrepreneurs, equity, genomics, investment, life sciences, medical device, software, university, venture capital 
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal Comments are closed Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, licensing, life sciences, pharmaceuticals 
The personal genetics company 23andMe is closing down access to its raw genomic data for independent software developers. . . . → Read More: UPDATE: 23andMe Shuts Down Open API Access to Raw Data Comments are closed Joint ventures/collaborations biomedical, engineering, life sciences, medical device, software 
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies 2 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences 
An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide. . . . → Read More: Bread Wheat Genome Sequenced Comments are closed Joint ventures/collaborations, New products agriculture, biotechnology, genomics, life sciences, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
